Soleno Therapeutics(SLNO) - 2025 Q4 - Earnings Call Transcript

Soleno Therapeutics (NasdaqCM:SLNO) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsAnish Bhatnagar - Chairman and CEOBrian Ritchie - Managing DirectorBrian Skorney - Managing Director of BiotechnologyJim Mackaness - CFOKhalil Fenina - Equity Research Associate of BiotechnologyMeredith Manning - Chief Commercial OfficerMoritz Reiterer - Biotechnology Equity Research AssociateRam Selvaraju - Managing Director of Healthcare Equity ResearchShannon Duffy - Biotech Equity Research Associa ...